Penumbra, Inc. (PEN)
323.79
-1.39
(-0.43%)
USD |
NYSE |
Aug 24, 16:00
323.79
0.00 (0.00%)
After-Hours: 20:00
Penumbra Shareholders Equity (Quarterly) : 1.531B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.531B |
| March 31, 2026 | 1.474B |
| December 31, 2025 | 1.428B |
| September 30, 2025 | 1.359B |
| June 30, 2025 | 1.294B |
| March 31, 2025 | 1.213B |
| December 31, 2024 | 1.151B |
| September 30, 2024 | 1.104B |
| June 30, 2024 | 1.161B |
| March 31, 2024 | 1.204B |
| December 31, 2023 | 1.179B |
| September 30, 2023 | 1.104B |
| June 30, 2023 | 1.067B |
| March 31, 2023 | 1.024B |
| December 31, 2022 | 998.86M |
| September 30, 2022 | 973.75M |
| June 30, 2022 | 970.02M |
| March 31, 2022 | 959.30M |
| December 31, 2021 | 953.93M |
| September 30, 2021 | 690.94M |
| June 30, 2021 | 678.93M |
| March 31, 2021 | 655.09M |
| December 31, 2020 | 641.50M |
| Date | Value |
|---|---|
| September 30, 2020 | 622.41M |
| June 30, 2020 | 624.79M |
| March 31, 2020 | 488.93M |
| December 31, 2019 | 485.89M |
| September 30, 2019 | 467.33M |
| June 30, 2019 | 454.09M |
| March 31, 2019 | 436.73M |
| December 31, 2018 | 422.24M |
| September 30, 2018 | 409.42M |
| June 30, 2018 | 425.20M |
| March 31, 2018 | 414.92M |
| December 31, 2017 | 400.41M |
| September 30, 2017 | 383.83M |
| June 30, 2017 | 372.98M |
| March 31, 2017 | 373.47M |
| December 31, 2016 | 266.55M |
| September 30, 2016 | 253.85M |
| June 30, 2016 | 247.59M |
| March 31, 2016 | 238.05M |
| December 31, 2015 | 232.53M |
| September 30, 2015 | 228.62M |
| June 30, 2015 | 100.40M |
| March 31, 2015 | 101.51M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Boston Scientific Corp. | 24.93B |
| Globus Medical, Inc. | 4.769B |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Teleflex, Inc. | 2.905B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.975B |
| Total Liabilities (Quarterly) | 443.96M |
| Debt to Equity Ratio | 0.139 |
| Current Ratio | 5.750 |
| Net Debt Paydown Yield | 0.01% |